These companies provide the critical temperature-controlled systems that Brazil's massive food export industry simply cannot function without. As Brazil's agricultural exports grow, so does demand for their services.
You're investing in proven international specialists rather than emerging market risks. These firms have established networks and technology that developing food economies worldwide depend on.
With global population growth and rising food quality standards, the need for sophisticated cold chain infrastructure is accelerating. These companies are positioned at the centre of this expanding market.
Market capitalisation summary and investor key takeaways for the supplied basket.
COLD: $3.61B
UGP: $4.42B
Brazil's position as a global food powerhouse depends entirely on sophisticated cold chain infrastructure. From farm to port, temperature-controlled systems prevent spoilage and ensure products meet international standards. We've identified the global technology leaders that make this multi-billion dollar industry possible.
This group focuses on US and EU-listed companies rather than Brazilian firms directly. These are the global specialists in refrigerated transport, temperature-controlled warehousing, and monitoring systems that Brazil's food exporters rely on. It's a way to invest in Brazil's agricultural success through proven international technology leaders.
These companies were handpicked as the essential enablers of Brazil's food export economy. They include specialised REITs owning temperature-controlled warehouses, industrial technology firms manufacturing refrigeration units, and logistics giants managing complex cold supply chains globally.
As a global food powerhouse, Brazil's economic growth relies on preserving perishable goods from farm to port. This basket offers potential exposure to the US and EU-listed technology and logistics companies that provide critical refrigeration, warehousing, and monitoring infrastructure.
10월 31 게시
Here are a few of the assets in this group. Create an account to unlock the full list.
Join Nemo FREE today and unlock every stock
60초면 충분합니다.
이 바스켓의 전체 스토리를 확인하세요. 리스크와 잠재력을 다룬 상세 기사를 읽어보세요.
인사이트 전체 읽기
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
애널리스트들은 이 그룹의 자산이 향후 1년간 평균 25.35% 성장할 것으로 예상합니다.
이 그룹의 자산 3개 중 1개가 전문 애널리스트로부터 매수 의견을 받았습니다.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
이 자산들에 투자했다면:
12개월 후 예상 가치:
+25.35%
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
